Nisa Investment Advisors’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$441 Buy
628
+388
+162% +$362 ﹤0.01% 2879
2025
Q4
$372 Sell
240
-2,860
-92% -$4.57K ﹤0.01% 2854
2025
Q3
$4.9K Sell
3,100
-52
-2% -$90 ﹤0.01% 2445
2025
Q2
$6.87K Sell
3,152
-8,610
-73% -$20.8K ﹤0.01% 2386
2025
Q1
$32.1K Sell
11,762
-213
-2% -$840 ﹤0.01% 1727
2024
Q4
$49.8K Buy
11,975
+234
+2% +$884 ﹤0.01% 1685
2024
Q3
$45.7K Sell
11,741
-235
-2% -$990 ﹤0.01% 1671
2024
Q2
$46.9K Buy
11,976
+29
+0.2% +$125 ﹤0.01% 1689
2024
Q1
$50.1K Buy
11,947
+147
+1% +$690 ﹤0.01% 1652
2023
Q4
$55.5K Buy
11,800
+11,775
+47,100% +$45.8K ﹤0.01% 1615
2023
Q3
$78 Sell
25
-50
-67% -$201 ﹤0.01% 2750
2023
Q2
$344 Buy
75
+45
+150% +$207 ﹤0.01% 2636
2023
Q1
$0 Sell
30
-4,468
-99% -$22K ﹤0.01% 2630
2022
Q4
$25K Hold
4,498
﹤0.01% 1994
2022
Q3
$31K Buy
4,498
+98
+2% +$547 ﹤0.01% 1913
2022
Q2
$21K Buy
4,400
+1,400
+47% +$6.9K ﹤0.01% 2038
2022
Q1
$21K Sell
3,000
-4,982
-62% -$34K ﹤0.01% 2041
2021
Q4
$52K Buy
+7,982
New +$85.7K ﹤0.01% 1721

Other funds holding MXCT

Nisa Investment Advisors's MXCT Position: Q1 2026 in Review

Nisa Investment Advisors increased its MaxCyte (MXCT) stake by 162% in Q1 2026, buying an estimated $362 and bringing the position to 628 shares worth $441. The position accounts for ﹤0.01% of the portfolio, ranked #2879.

Nisa Investment Advisors first reported a position in MXCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $55.5K in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

  • Nisa Investment Advisors held 628 shares of MaxCyte worth $441 as of Q1 2026.
  • Nisa Investment Advisors bought 388 MaxCyte shares in Q1 2026, an estimated $362.
  • MaxCyte made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2879 holding.
  • Nisa Investment Advisors first reported a position in MaxCyte in Q4 2021 and has held it in 18 quarters since.
  • Nisa Investment Advisors's MaxCyte position peaked at $55.5K in Q4 2023.
  • 130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.